[1] Tang JT, Fang JY. MicroRNA regulatory network in human colorectal cancer[J]. Mini Rev Med Chem, 2009, 9(8): 921-926.
[2] Xu X, Liu C, Bao J. Hypoxiainduced hsamiR101 promotes glycolysis by targeting TIGAR mRNA in clear cell renal cell carcinoma[J]. Mol Med Rep, 2017, 15(3): 1373-1378. DOI: 10.3892/mmr.2017.6139.
[3] Alla V, Kowtharapu BS, Engelmann D, et al. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl2 via the p73/DNp73miR205 circuitry[J]. Cell Cycle, 2012, 11(16): 30673078. DOI: 10.4161/cc.21476.
[4] Siouda M, Yue J, Shukla R, et al. Transcriptional regulation of the human tumor suppressor DOK1 by E2F1[J]. Mol Cell Biol, 2012, 32(23): 4877-4890. DOI: 10.1128/MCB.01050-12.
[5] Fang Z, Tang J, Bai Y, et al. Plasma levels of microRNA24, microRNA320a, and microRNA4235p are potential biomarkers for colorectal carcinoma[J]. J Exp Clin Cancer Res, 2015, 34: 86. DOI: 10.1186/s1304601501986.
[6] Vishnubalaji R, Hamam R, Abdulla MH, et al. Genomewide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer[J]. Cell Death Dis, 2015, 6: e1614. DOI: 10.1038/cddis.2014.556.
[7] Wang H, Cao F, Li X, et al. miR320b suppresses cell proliferation by targeting cMyc in human colorectal cancer cells[J]. BMC Cancer, 2015, 15: 748. DOI: 10.1186/s12885-0151728-5.
[8] Vishnubalaji R, Hamam R, Yue S, et al. MicroRNA320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1[J]. Oncotarget, 2016, 7(24): 35789-35802. DOI: 10.18632/oncotarget.8937. |